As of 2023, the mortality due to bladder malignant neoplasms in Japan stood at approximately 9.76 thousand deaths. From 2024 onwards, forecasts indicate a steady increase in mortalities: 9.93 thousand in 2024, 10.12 thousand in 2025, 10.3 thousand in 2026, 10.48 thousand in 2027, and 10.66 thousand in 2028. This shows an average annual growth rate (CAGR) of around 1.8% over the five-year forecast period, with year-on-year increases suggesting a rising trend in deaths due to this condition.
Future trends worth monitoring include the impact of advancements in medical treatments and diagnostics for bladder cancer, changes in lifestyle or environmental factors influencing cancer rates, and government policies on health and cancer awareness initiatives. Additionally, emerging technologies and innovations in healthcare delivery may alter these trends significantly.
